Yes a commercial valuation is required immediately of the Company and its IP Suite.
You will note that RAP BOD have had to at the request of SH gain a Commercial Valuation of the Company before further negotiations with Pfizer.
Standard Business Operating Procedure..
So PAA have booked a Facility for the Humanised Mouse Trial according to Roger ,, and the last announcement , so why keep it secret? where? When? who? duration?
Roger back in Oxford , might want to get a PAA backdrop or at least wind that clock up....
I have some near opportunities to move to , regrettably with no clear timeline here we can only expect further decline until a clear timeline is put forward,,, every trial at this company has been delayed in excess of a year. Not sure cancelling a Trial is a saving to SH?? more like a little more cash to stave off an immediate CR and if we have saved $1.5 then why the need for the Factoring in from a Finance company for the R &D rebates.
More twists than the Da Vinci Code....
Many where holding on for the Human Covid Trial as it would have been short ... now its been reduced to a mouse sometime in the future?
This after 6 announcements identifying Ergomed? Poland????????? are you &%&*^*ng joking..
Company has isolated itself from the rest of the Biotech sector by not participating in the same manner,,,
Best of luck to all holders,,,NZT
- Forums
- ASX - By Stock
- PAA
- Clinical Trials Interview June 2022
Clinical Trials Interview June 2022, page-9
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
16.5¢ |
Change
0.005(3.13%) |
Mkt cap ! $75.36M |
Open | High | Low | Value | Volume |
16.0¢ | 16.5¢ | 15.5¢ | $77.21K | 474.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 73586 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.5¢ | 274 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 73586 | 0.160 |
12 | 193958 | 0.155 |
15 | 357945 | 0.150 |
5 | 182834 | 0.145 |
4 | 118342 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.165 | 274 | 2 |
0.170 | 245111 | 7 |
0.175 | 1008034 | 5 |
0.180 | 269093 | 7 |
0.185 | 52000 | 2 |
Last trade - 11.58am 23/08/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
Previous Video
Next Video
SPONSORED BY The Market Online